Mark R. Olsen
Expertise in
57
conditions

Dr. Mark R. Olsen

Oncology
Oklahoma Cancer Specialists And Research Institute
12697 E 51st St, 
Tulsa, OK 
Accepting New Patients
Expertise in
57
conditions
Oklahoma Cancer Specialists And Research Institute
12697 E 51st St, 
Tulsa, OK 

Overview

Mark Roger Olsen, MD, is a board-certified, independent medical oncologist at Ascension St. John in Tulsa, Oklahoma. Dr. Olsen diagnoses and treats cancer using medications, such as chemotherapy, immunotherapy and targeted therapies. Every appointment with Dr. Olsen starts with a conversation. He takes the time to answer all your questions - big and small.

Dr. Olsen is highly rated in 57 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Embryonal Tumor with Multilayered Rosettes, and Neuroepithelioma.

Dr. Olsen is board certified in The American Board Of Internal Medicine - Medical Oncology. He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 3 clinical trials. Dr. Olsen is currently accepting new patients.

Graduate Institution

University Of Wisconsin Medical School

Residency

University of Wisconsin Medical School

Specialties

Oncology

Licenses

Internal Medicine in OK

Board Certifications

The American Board Of Internal Medicine - Medical Oncology

Fellowships

University of Wisconsin Medical School

Hospital Affiliations

Ascension St. John Medical Center
Ascension St John Medical Center
Cherokee Nation W W Hastings Indian Hospital
Saint Francis Hospital South, LLC
Saint Francis Hospital, Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
CommunityCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SelectHealth
  • HMO
  • POS
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Oklahoma Cancer Specialists And Research Institute
12697 E 51st St, Tulsa, OK 74146
Other Locations
Oklahoma Cancer Specialist and Research Institute
12697 E 51st St, Tulsa, OK 74146

Additional Areas of Focus

Dr. Olsen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
A Phase 1b (Open-Label)/Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma
A Phase 1b (Open-Label)/Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Drug
Study Drugs: Olaratumab, Gemcitabine, Docetaxel
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

8 Total Publications

Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Journal: Cancer
Published: July 06, 2021
Similar Doctors
Expertise in
45
conditions
Dr. Jihad Khattab
Hematology | Oncology
Expertise in
45
conditions
Dr. Jihad Khattab
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (0.9 miles away)
918-556-3000
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Jihad Khattab is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Khattab is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Khattab is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Oklahoma Cancer Specialist And Research Institute

12697 E 51st St, 
Tulsa, OK 
 (0.1 miles away)
918-505-3200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daron G. Street, MD, is an independent gynecologic oncologist at Ascension St. John in Tulsa, Oklahoma. He diagnoses and treats women's reproductive cancer affecting the cervix, uterus and ovaries and vulva. Dr. Street is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Endometrial Cancer, and Hernia Surgery. Dr. Street is board certified in The American Board Of Obstetrics And Gynecology - Gynecologic Oncology and The American Board Of Obstetrics And Gynecology - Obstetrics And Gynecology. Dr. Street is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Oklahoma Cancer Specialist And Research Institute

12697 E 51st St, 
Tulsa, OK 
 (0.1 miles away)
918-505-3200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alfred D. Jenkins, MD, is an independent gynecologic oncologist at Ascension St. John in Tulsa, Oklahoma. He diagnoses and treats women's reproductive cancer affecting the cervix, uterus and ovaries and vulva. Dr. Jenkins is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Salpingo-Oophorectomy, and Bladder Reconstruction. Dr. Jenkins is board certified in The American Board Of Obstetrics And Gynecology - Gynecologic Oncology and The American Board Of Obstetrics And Gynecology - Obstetrics And Gynecology. Dr. Jenkins is currently accepting new patients.

Frequently Asked Questions about Dr. Mark R. Olsen

How do I make an appointment with Dr. Mark R. Olsen?

You can book an appointment with Dr. Mark R. Olsen by calling their office at 918-505-3200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark R. Olsen a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark R. Olsen is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark R. Olsen specialize in?

While Dr. Mark R. Olsen is a Oncology, they have specific expertise in Familial Colorectal Cancer, Colorectal Cancer, and Embryonal Tumor with Multilayered Rosettes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Mark R. Olsen participate in research or clinical trials?

Yes. Dr. Mark R. Olsen has published 8 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Mark R. Olsen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark R. Olsen accept my insurance?

Dr. Mark R. Olsen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 918-505-3200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Olsen's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 49 Advanced Conditions
    View All 93 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile